相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk Predictivity
Daniel Ho et al.
FRONTIERS IN GENETICS (2022)
The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings
Volha Skrahina et al.
MOVEMENT DISORDERS (2021)
Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis
Maren Stolp Andersen et al.
ANNALS OF NEUROLOGY (2021)
Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes
Gloriia Novikova et al.
NATURE COMMUNICATIONS (2021)
Parkinson's Disease Subtypes: Critical Appraisal and Recommendations
Tiago A. Mestre et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease
Sebastian Koch et al.
GENES (2021)
Parkinson's disease
Bastiaan R. Bloem et al.
LANCET (2021)
Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's Disease
Marco Toffoli et al.
MOVEMENT DISORDERS (2021)
Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a Subgroup
Justin M. O'Sullivan et al.
MOVEMENT DISORDERS (2021)
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease
Ganqiang Liu et al.
NATURE GENETICS (2021)
Prodromal Parkinson disease subtypes - key to understanding heterogeneity
Daniela Berg et al.
NATURE REVIEWS NEUROLOGY (2021)
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial
Michael A. Schwarzschild et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Wearable sensors enable personalized predictions of clinical laboratory measurements
Jessilyn Dunn et al.
NATURE MEDICINE (2021)
The Role of Intermittent Fasting in Parkinson's Disease
Bryan J. Neth et al.
FRONTIERS IN NEUROLOGY (2021)
Network medicine in Cardiovascular Research
Laurel Y. Lee et al.
CARDIOVASCULAR RESEARCH (2021)
Network medicine in Cardiovascular Research
Laurel Y. Lee et al.
CARDIOVASCULAR RESEARCH (2021)
CellWalker integrates single-cell and bulk data to resolve regulatory elements across cell types in complex tissues
Pawel F. Przytycki et al.
GENOME BIOLOGY (2021)
Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease
Manuela M. X. Tan et al.
MOVEMENT DISORDERS (2021)
Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-present)
Xiao Ding et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease
Susanne A. Schneider et al.
JOURNAL OF NEUROLOGY (2020)
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Alberto J. Espay et al.
NEUROLOGY (2020)
被撤回的出版物: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease (Retracted article. See vol. 90, pg. 329, 2021)
Sebastian Heinzel et al.
ANNALS OF NEUROLOGY (2020)
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations A Nonrandomized, Noncontrolled Trial
Stephen Mullin et al.
JAMA NEUROLOGY (2020)
The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease
Julia L. Y. Cheong et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson's disease
Julien Bryois et al.
NATURE GENETICS (2020)
Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset
William Schierding et al.
MOVEMENT DISORDERS (2020)
Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression?
Grace F. Crotty et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Single cell transcriptomics comes of age
Sarah Aldridge et al.
NATURE COMMUNICATIONS (2020)
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)
Andrea Sturchio et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
PR001 gene therapy improved phenotypes in models of Parkinson’s disease with GBA1 mutation
Patty Sheehan et al.
Alzheimers & Dementia (2020)
Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014
Marie Villumsen et al.
GUT (2019)
Integrative single-cell analysis
Tim Stuart et al.
NATURE REVIEWS GENETICS (2019)
Exploring the Multiple-Hit Hypothesis of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat
Kristin L. Patrick et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Levodopa treatment in Parkinson's disease: earlier or later?
Federico Paolini Paoletti et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich et al.
PARKINSONISM & RELATED DISORDERS (2019)
A Genome-wide Framework for Mapping Gene Regulation via Cellular Genetic Screens
Molly Gasperini et al.
CELL (2019)
The association between lifestyle factors and Parkinson's disease progression and mortality
Kimberly C. Paul et al.
MOVEMENT DISORDERS (2019)
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
Mike A. Nalls et al.
LANCET NEUROLOGY (2019)
Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis
Michaela E. Johnson et al.
TRENDS IN NEUROSCIENCES (2019)
Double-slit photoelectron interference in strong-field ionization of the neon dimer
Maksim Kunitski et al.
NATURE COMMUNICATIONS (2019)
Making the switch: From case studies to N-of-1 trials
Amanda Margolis et al.
EPILEPSY & BEHAVIOR REPORTS (2019)
State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease
Sneha Mantri et al.
NPJ PARKINSONS DISEASE (2019)
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
Kwangsik Nho et al.
JAMA NETWORK OPEN (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine
Kivilcim Ozturk et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study
Naveed Malek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Precision Medicine in Parkinson's Disease - Exploring Patient-Initiated Self-Tracking
Sara Riggare et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Parkinson Diseases in the 2020s and Beyond: Replacing Clinico-Pathologic Convergence With Systems Biology Divergence
Alberto J. Espay et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Biomarker-Driven Phenotyping in Parkinson's Disease: A Translational Missing Link in Disease-Modifying Clinical Trials
Alberto J. Espay et al.
MOVEMENT DISORDERS (2017)
Precision medicine for disease modification in Parkinson disease
Alberto J. Espay et al.
NATURE REVIEWS NEUROLOGY (2017)
The infinitesimal model: Definition, derivation, and implications
N. H. Barton et al.
THEORETICAL POPULATION BIOLOGY (2017)
The Threshold Theory for Parkinson's Disease
Simone Engelender et al.
TRENDS IN NEUROSCIENCES (2017)
An Expanded View of Complex Traits: From Polygenic to Omnigenic
Evan A. Boyle et al.
CELL (2017)
Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter Assay
Ryan Tewhey et al.
CELL (2016)
Accuracy of clinical diagnosis of Parkinson disease A systematic review and meta-analysis
Giovanni Rizzo et al.
NEUROLOGY (2016)
Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology
Simon G. Coetzee et al.
SCIENTIFIC REPORTS (2016)
Gastrointestinal dysfunction in Parkinson's disease
Alfonso Fasano et al.
LANCET NEUROLOGY (2015)
Time for one-person trials
Nicholas J. Schork
NATURE (2015)
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies
Brendan K. Bulik-Sullivan et al.
NATURE GENETICS (2015)
Non-motor symptoms in an Indian cohort of Parkinson's disease patients and correlation of progression of non-motor symptoms with motor worsening
Amruta Raven et al.
NEUROLOGY INDIA (2015)
PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
Alastair J. Noyce et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Exposure to pesticides or solvents and risk of Parkinson disease
Gianni Pezzoli et al.
NEUROLOGY (2013)
Paths from Pesticides to Parkinson's
Freya Kamel
SCIENCE (2013)
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
M. Anheim et al.
NEUROLOGY (2012)
Network medicine: a network-based approach to human disease
Albert-Laszlo Barabasi et al.
NATURE REVIEWS GENETICS (2011)
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Elizabeth O. Lillie et al.
PERSONALIZED MEDICINE (2011)
LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease
Z. Gan-Or et al.
NEUROGENETICS (2010)
There is no Parkinson disease
William J. Weiner
ARCHIVES OF NEUROLOGY (2008)
The Parkinson's complex: Parkinsonism is just the tip of the iceberg
JW Langston
ANNALS OF NEUROLOGY (2006)